- Home
- MXCT vs CYBN Comparison
MXCT vs CYBN Comparison
Compare MXCT & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MXCT
- CYBN
- Stock Information
- Founded
- MXCT 1999
- CYBN 2019
- Country
- MXCT United States
- CYBN Canada
- Employees
- MXCT N/A
- CYBN N/A
- Industry
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CYBN Pharmaceuticals and Biotechnology
- Sector
- MXCT Health Care
- CYBN Health Care
- Exchange
- MXCT Nasdaq
- CYBN Nasdaq
- Market Cap
- MXCT 159.9M
- CYBN 147.4M
- IPO Year
- MXCT 2021
- CYBN N/A
- Fundamental
- Price
- MXCT $1.67
- CYBN $5.95
- Analyst Decision
- MXCT Buy
- CYBN Strong Buy
- Analyst Count
- MXCT 4
- CYBN 3
- Target Price
- MXCT $7.50
- CYBN $85.00
- AVG Volume (30 Days)
- MXCT 561.6K
- CYBN 1.1M
- Earning Date
- MXCT 11-12-2025
- CYBN 11-17-2025
- Dividend Yield
- MXCT N/A
- CYBN N/A
- EPS Growth
- MXCT N/A
- CYBN N/A
- EPS
- MXCT N/A
- CYBN N/A
- Revenue
- MXCT $35,754,000.00
- CYBN N/A
- Revenue This Year
- MXCT N/A
- CYBN N/A
- Revenue Next Year
- MXCT $14.72
- CYBN N/A
- P/E Ratio
- MXCT N/A
- CYBN N/A
- Revenue Growth
- MXCT N/A
- CYBN N/A
- 52 Week Low
- MXCT $1.26
- CYBN $4.81
- 52 Week High
- MXCT $5.20
- CYBN $13.88
- Technical
- Relative Strength Index (RSI)
- MXCT 54.49
- CYBN 43.28
- Support Level
- MXCT $1.45
- CYBN $6.86
- Resistance Level
- MXCT $1.57
- CYBN $8.00
- Average True Range (ATR)
- MXCT 0.11
- CYBN 0.49
- MACD
- MXCT -0.00
- CYBN -0.01
- Stochastic Oscillator
- MXCT 71.40
- CYBN 10.48
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.